The Connection Between Statins, Memory Loss &

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
164
The Connection Between Statins, Memory Loss & Dementia

OMG OMG OMG

https://bebrainfit.com/statins-memory-loss/

If you’ve been diagnosed with high cholesterol, it’s very likely your doctor prescribed a type of cholesterol-lowering drug called a statin.

Statins, also known as HMG-CoA reductase inhibitors, are the most commonly prescribed drugs in the world — and among the most profitable. (1)

Over one in five Americans between the ages of 40 and 75 takes these drugs ostensibly to prevent a heart attack or stroke. (2)

We are currently experiencing epidemics of memory loss, dementia, and Alzheimer’s disease (now the sixth leading cause of death in the US). (3)

This may not be a coincidence.

Is there a connection between taking statins and the rise in memory loss and dementia?

How Cholesterol Impacts Brain Health and Memory
Cholesterol has been demonized as a cause of heart disease, but it’s less known as an essential component of brain cells.

Cholesterol occurs in particularly high concentrations in the brain.

Your brain is 60% fat with much of that being cholesterol.

Without adequate cholesterol, your brain cells would die.

Cholesterol is needed to make neurotransmitters — chemicals brain cells use to communicate with each other.

Related on Be Brain Fit —
Balancing Neurotransmitters to Take Control of Your Life

Neurotransmitters regulate your mood, your ability to focus, learn, remember, and handle stress.

Abnormal neurotransmitter activity is responsible for many nervous system diseases and psychiatric disorders.

Even your doctor may not know that high total cholesterol actually reduces the risk of dementia in the elderly. (4)

But she certainly knows that cholesterol-lowering drugs can cause memory loss since this well-established side effect is listed on every prescription bottle. (5)

Statin Side Effects: Memory Loss, Depression, and More
There is no doubt that cholesterol-lowering statin drugs like Mevacor, Lipitor, and Crestor are linked to serious memory loss, fuzzy thinking, and learning difficulties. (6)

Statins decrease the production of CoQ10, a nutrient that’s protective of both the heart and the brain.

CoQ10 deficiency is believed responsible for the fatigue and muscle pain commonly experienced from statin drug use. (7)

Some people get very irritable, depressed, anxious, or even suicidal when taking these drugs or when following a low-fat diet. (8, 9)

Related on Be Brain Fit —
Drugs That Cause Memory Loss (& what you can do)

The US Food and Drug Administration requires that warning labels state that statins can cause memory loss as well as mental confusion, liver problems, and type 2 diabetes. (10)

Statins can lead to diabetes at an alarming rate.

Research has found that nearly half of women who take these medications eventually develop diabetes, a disease which greatly increases your risk for dementia. (11, 12)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 141

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 206

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 265

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Milestone Scientific Gains Approval for Federal Supply Schedule

Updated Category News Views 102

Milestone Scientific's Key Approval for CompuFlo® System Milestone Scientific Inc. (MLSS), a prominent name in the medical technology industry, has recently achieved a significant milestone by securing approval for the Federal Supply Schedule (FSS) concerning its CompuFlo® Epidural System. This news marks a substantial step for the company, which specializes in...

Continue Reading
Small Business Confidence Surges Ahead of 2026, Report Reveals

Updated Category News Views 321

Small Businesses Show Robust Resilience for 2026 As we approach a new year, the outlook for small businesses is remarkably positive, despite facing significant challenges from tariffs and inflation. The Comerica Small Business Pulse Index™ has released findings showcasing that small business owners nationwide are mostly hopeful about 2026, with many predicting growth...

Continue Reading
Investors Speak Out: Trade Desk, Inc. Class Action Unfolding

Updated Category News Views 98

Understanding the Trade Desk Class Action Lawsuit Trade Desk, Inc., renowned for its innovative advertising technology, is currently facing a class action lawsuit that has captured the attention of many investors and legal experts alike. The lawsuit, recently filed, comes on the heels of troubling financial results indicating severe challenges in the company's recent...

Continue Reading
Kalmar Corporation Prepares for 2024 Financial Statement Release

Updated Category News Views 115

Kalmar Corporation's Upcoming Financial Statements Review Kalmar Corporation is gearing up to unveil its much-anticipated financial statements review for the year 2024. Scheduled for release at approximately 9:00 a.m. EET, the report promises to offer a comprehensive look into the company’s financial health and operational successes over the past year. Details About the...

Continue Reading
Analyzing the Short Interest Trends for AutoZone Inc

Updated Category News Views 96

Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...

Continue Reading